Zeiher Bernhardt G
SEC CIK 1971421 · EDGAR
BoughtSold
Most active insiders at TRDA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PARMAR KUSH | Dir, 10% | — | $3.65M |
| 2 | MPM BIOVENTURES 2018, L.P. | 10% | — | $3.60M |
| 3 | MPM BioVentures 2014, L.P. | 10% | — | $3.60M |
| 4 | 5AM Ventures V, L.P. | 10% | — | $3.00M |
| 5 | Baker Bros. Advisors (GP) LLC | 10% | $1.35M | — |
| 6 | WENTWORTH KORY JAMES | CFO | — | $433.6K |
| 7 | Dowden Nathan J | Pres, COO | — | $425.7K |
| 8 | Sethuraman Natarajan | Pres, Research, Develop | — | $398.8K |
| 9 | BAKER FELIX | 10% | $261.8K | — |
| 10 | Zeiher Bernhardt G | Dir | $29.3K | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-05-21 16:31 | 2026-05-20 | TRDA | Entrada Therapeutics, Inc. | Zeiher Bernhardt G | Dir | P - Purchase | $5.86 | +5,000 | 5,000 | New | +$29.3K |
| 2026-01-27 | 2026-01-26 | ABEO | ABEONA THERAPEUTICS INC. | Zeiher Bernhardt G | Dir | A - Grant | $0.00 | +37.3K | 84.5K | +79% | $0 | |
| 2025-03-24 | 2025-03-20 | AMLX | Amylyx Pharmaceuticals, Inc. | Zeiher Bernhardt G | Dir | P - Purchase | $3.70 | +10.0K | 10.0K | New | +$37.0K | |
| 2025-02-03 | 2025-01-31 | ABEO | ABEONA THERAPEUTICS INC. | Zeiher Bernhardt G | Dir | A - Grant | $0.00 | +36.1K | 47.1K | +327% | $0 | |
| 2024-08-14 | 2024-08-13 | ABEO | ABEONA THERAPEUTICS INC. | Zeiher Bernhardt G | Dir | A - Grant | $0.00 | +11.0K | 11.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations